Abstract
Cefbuperazone (BMY 25182), a new cephamycin, showed activity similar to those of moxalactam and other cephalosporin-cephamycins against aerobic and anaerobic bacteria from female genital tract infections. MICs of the antimicrobial agents were less than or equal to 16 micrograms/ml for greater than 97% of organisms tested. All of the anaerobic bacteria tested were susceptible to clindamycin, metronidazole, and chloramphenicol.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cunningham F. G., Hemsell D. L., DePalma R. T., Kappus S., Roark M., Nobles B. Moxalactam for obstetric and gynecologic infections. In vitro and dose-finding studies. Am J Obstet Gynecol. 1981 Apr 15;139(8):915–921. doi: 10.1016/0002-9378(81)90958-3. [DOI] [PubMed] [Google Scholar]
- Hemsell D. L., Cunningham F. G., DePalma R. T., Nobles B. J., Heard M., Hemsell P. G. Cefotaxime sodium therapy for endomyometritis following cesarean section: dose-finding and comparative studies. Obstet Gynecol. 1983 Oct;62(4):489–497. [PubMed] [Google Scholar]
- Ohm-Smith M. J., Hadley W. K., Sweet R. L. In vitro activity of new beta-lactam antibiotics and other antimicrobial drugs against anaerobic isolates from obstetric and gynecological infections. Antimicrob Agents Chemother. 1982 Oct;22(4):711–714. doi: 10.1128/aac.22.4.711. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sweet R. L., Ledger W. J. Cefoxitin: single-agent treatment of mixed aerobic-anaerobic pelvic infections. Obstet Gynecol. 1979 Aug;54(2):193–198. [PubMed] [Google Scholar]
- Sweet R. L., Robbie M. O., Ohm-Smith M., Hadley W. K. Comparative study of piperacillin versus cefoxitin in the treatment of obstetric and gynecologic infections. Am J Obstet Gynecol. 1983 Feb 1;145(3):342–349. doi: 10.1016/0002-9378(83)90722-6. [DOI] [PubMed] [Google Scholar]
- Tai M., Fukuoka Y., Yotsuji A., Kumano K., Takahata M., Mikami H., Yasuda T., Saikawa I., Mitsuhashi S. In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic. Antimicrob Agents Chemother. 1982 Nov;22(5):728–734. doi: 10.1128/aac.22.5.728. [DOI] [PMC free article] [PubMed] [Google Scholar]